tiprankstipranks
Mettler-Toledo International (GB:0K10)
LSE:0K10
UK Market
0K10
Mettler-Toledo
RESEARCH TOOLSreports

Mettler-Toledo (0K10) Share Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

0K10 Analyst Ratings

Moderate Buy
12Ratings
Moderate Buy
6 Buy
5 Hold
1 Sell
Based on 12 analysts giving stock ratings to
Mettler-Toledo
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

0K10 Stock 12 Month Forecast

Average Price Target

$1,455.45
▲(9.40% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for Mettler-Toledo in the last 3 months. The average price target is $1,455.45 with a high forecast of $1,600.00 and a low forecast of $1,200.00. The average price target represents a 9.40% change from the last price of $1,330.43.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1182":"$1,182","1601":"$1,601","1286.75":"$1,286.8","1391.5":"$1,391.5","1496.25":"$1,496.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1600,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.60K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1455.4545454545455,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$1.46K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1200,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$1.20K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1182,1286.75,1391.5,1496.25,1601],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1377.02,1394.1723076923076,1411.3246153846153,1428.476923076923,1445.6292307692308,1462.7815384615385,1479.9338461538462,1497.0861538461538,1514.2384615384615,1531.3907692307691,1548.543076923077,1565.6953846153847,1582.8476923076923,{"y":1600,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1377.02,1383.0534265734266,1389.0868531468532,1395.1202797202798,1401.1537062937064,1407.187132867133,1413.2205594405596,1419.253986013986,1425.2874125874125,1431.3208391608391,1437.3542657342657,1443.3876923076923,1449.421118881119,{"y":1455.4545454545455,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1377.02,1363.403076923077,1349.7861538461539,1336.1692307692308,1322.5523076923077,1308.9353846153847,1295.3184615384616,1281.7015384615383,1268.0846153846153,1254.4676923076922,1240.8507692307692,1227.2338461538461,1213.616923076923,{"y":1200,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1292.14,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1272.41,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1418.48,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1474.56,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1400.12,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1369.83,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1327.88,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1283.06,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1271.8,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1183.26,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1310,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1395.42,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1377.02,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$1,600Average Price Target$1,455Lowest Price Target$1,200
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Rothschild & Co Redburn Analyst forecast on GB:0K10
Natalya Davies
Rothschild & Co Redburn
Rothschild & Co Redburn
$1,200
Sell
-9.80%
Downside
Initiated
09/02/26
Mettler-Toledo initiated with a Sell at Rothschild & Co RedburnMettler-Toledo initiated with a Sell at Rothschild & Co Redburn
RBC Capital Analyst forecast on GB:0K10
Dan Leonard
RBC Capital
RBC Capital
$1,515
Hold
13.87%
Upside
Initiated
09/01/26
Mettler-Toledo initiated with a Sector Perform at RBC CapitalMettler-Toledo initiated with a Sector Perform at RBC Capital
Morgan Stanley Analyst forecast on GB:0K10
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
$1,275→$1,450
Hold
8.99%
Upside
Assigned
08/04/26
Mettler-Toledo: Robust Q2 and Raised Guidance Drive Price Target Increase to $1,450, But Valuation Keeps Rating at Hold
J.P. Morgan Analyst forecast on GB:0K10
Casey Woodring
J.P. Morgan
J.P. Morgan
$1,200→$1,400
Hold
5.23%
Upside
Reiterated
08/04/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Neuren Pharmaceuticals Limited (Other OTC: NURPF), Mettler-Toledo (NYSE: MTD) and Dexcom (NASDAQ: DXCM)
Wells Fargo Analyst forecast on GB:0K10
Unknown Analyst
Wells Fargo
Not Ranked
Wells Fargo
$1,225→$1,450
Hold
8.99%
Upside
Assigned
08/03/26
Wells Fargo Sticks to Their Hold Rating for Mettler-Toledo (MTD)
Barclays Analyst forecast on GB:0K10
Luke Sergott
Barclays
Barclays
$1,300→$1,575
Buy
18.38%
Upside
Reiterated
08/03/26
Analysts Offer Insights on Healthcare Companies: Mettler-Toledo (NYSE: MTD), AnaptysBio (NASDAQ: ANAB) and Alnylam Pharma (NASDAQ: ALNY)
Stifel Nicolaus Analyst forecast on GB:0K10
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
$1,400→$1,600
Buy
20.26%
Upside
Reiterated
08/03/26
Analysts Offer Insights on Healthcare Companies: Disc Medicine (NASDAQ: IRON), Mettler-Toledo (NYSE: MTD) and Moderna (NASDAQ: MRNA)
Jefferies Analyst forecast on GB:0K10
Tycho Peterson
Jefferies
Jefferies
$1,400→$1,580
Buy
18.76%
Upside
Reiterated
07/31/26
Mettler-Toledo price target raised to $1,580 from $1,400 at JefferiesMettler-Toledo price target raised to $1,580 from $1,400 at Jefferies
Bank of America Securities Analyst forecast on GB:0K10
Michael Ryskin
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
07/31/26
Analysts Offer Insights on Healthcare Companies: AptarGroup (NYSE: ATR), Mettler-Toledo (NYSE: MTD) and Dexcom (NASDAQ: DXCM)
Goldman Sachs Analyst forecast on GB:0K10
Evie Koslosky
Goldman Sachs
Goldman Sachs
$1,400→$1,340
Hold
0.72%
Upside
Reiterated
07/31/26
Hold Rating Maintained on Mettler-Toledo as Solid Q2 Results Lead to Higher Guidance but Price Target Trimmed from $1400 to $1340
Citi Analyst forecast on GB:0K10
Patrick B Donnelly
Citi
Citi
$1,550
Buy
16.50%
Upside
Reiterated
07/08/26
Analysts Offer Insights on Healthcare Companies: Helus Pharma (NASDAQ: HELP) and Mettler-Toledo (NYSE: MTD)
Evercore ISI Analyst forecast on GB:0K10
Vijay Kumar
Evercore ISI
Evercore ISI
$1,300→$1,350
Buy
1.47%
Upside
Reiterated
07/06/26
Mettler-Toledo price target raised to $1,350 from $1,300 at Evercore ISIMettler-Toledo price target raised to $1,350 from $1,300 at Evercore ISI
Wolfe Research Analyst forecast on GB:0K10
Michael Polark
Wolfe Research
Wolfe Research
$1,180
Hold
-11.31%
Downside
Initiated
06/01/26
Mettler-Toledo initiated with a Peer Perform at Wolfe ResearchMettler-Toledo initiated with a Peer Perform at Wolfe Research
Robert W. Baird Analyst forecast on GB:0K10
Catherine Ramsey Schulte
Robert W. Baird
Robert W. Baird
$1,445→$1,194
Hold
-10.25%
Downside
Reiterated
05/11/26
Mettler-Toledo price target lowered to $1,194 from $1,445 at BairdMettler-Toledo price target lowered to $1,194 from $1,445 at Baird
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Rothschild & Co Redburn Analyst forecast on GB:0K10
Natalya Davies
Rothschild & Co Redburn
Rothschild & Co Redburn
$1,200
Sell
-9.80%
Downside
Initiated
09/02/26
Mettler-Toledo initiated with a Sell at Rothschild & Co RedburnMettler-Toledo initiated with a Sell at Rothschild & Co Redburn
RBC Capital Analyst forecast on GB:0K10
Dan Leonard
RBC Capital
RBC Capital
$1,515
Hold
13.87%
Upside
Initiated
09/01/26
Mettler-Toledo initiated with a Sector Perform at RBC CapitalMettler-Toledo initiated with a Sector Perform at RBC Capital
Morgan Stanley Analyst forecast on GB:0K10
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
$1,275→$1,450
Hold
8.99%
Upside
Assigned
08/04/26
Mettler-Toledo: Robust Q2 and Raised Guidance Drive Price Target Increase to $1,450, But Valuation Keeps Rating at Hold
J.P. Morgan Analyst forecast on GB:0K10
Casey Woodring
J.P. Morgan
J.P. Morgan
$1,200→$1,400
Hold
5.23%
Upside
Reiterated
08/04/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Neuren Pharmaceuticals Limited (Other OTC: NURPF), Mettler-Toledo (NYSE: MTD) and Dexcom (NASDAQ: DXCM)
Wells Fargo Analyst forecast on GB:0K10
Unknown Analyst
Wells Fargo
Not Ranked
Wells Fargo
$1,225→$1,450
Hold
8.99%
Upside
Assigned
08/03/26
Wells Fargo Sticks to Their Hold Rating for Mettler-Toledo (MTD)
Barclays Analyst forecast on GB:0K10
Luke Sergott
Barclays
Barclays
$1,300→$1,575
Buy
18.38%
Upside
Reiterated
08/03/26
Analysts Offer Insights on Healthcare Companies: Mettler-Toledo (NYSE: MTD), AnaptysBio (NASDAQ: ANAB) and Alnylam Pharma (NASDAQ: ALNY)
Stifel Nicolaus Analyst forecast on GB:0K10
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
$1,400→$1,600
Buy
20.26%
Upside
Reiterated
08/03/26
Analysts Offer Insights on Healthcare Companies: Disc Medicine (NASDAQ: IRON), Mettler-Toledo (NYSE: MTD) and Moderna (NASDAQ: MRNA)
Jefferies Analyst forecast on GB:0K10
Tycho Peterson
Jefferies
Jefferies
$1,400→$1,580
Buy
18.76%
Upside
Reiterated
07/31/26
Mettler-Toledo price target raised to $1,580 from $1,400 at JefferiesMettler-Toledo price target raised to $1,580 from $1,400 at Jefferies
Bank of America Securities Analyst forecast on GB:0K10
Michael Ryskin
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
07/31/26
Analysts Offer Insights on Healthcare Companies: AptarGroup (NYSE: ATR), Mettler-Toledo (NYSE: MTD) and Dexcom (NASDAQ: DXCM)
Goldman Sachs Analyst forecast on GB:0K10
Evie Koslosky
Goldman Sachs
Goldman Sachs
$1,400→$1,340
Hold
0.72%
Upside
Reiterated
07/31/26
Hold Rating Maintained on Mettler-Toledo as Solid Q2 Results Lead to Higher Guidance but Price Target Trimmed from $1400 to $1340
Citi Analyst forecast on GB:0K10
Patrick B Donnelly
Citi
Citi
$1,550
Buy
16.50%
Upside
Reiterated
07/08/26
Analysts Offer Insights on Healthcare Companies: Helus Pharma (NASDAQ: HELP) and Mettler-Toledo (NYSE: MTD)
Evercore ISI Analyst forecast on GB:0K10
Vijay Kumar
Evercore ISI
Evercore ISI
$1,300→$1,350
Buy
1.47%
Upside
Reiterated
07/06/26
Mettler-Toledo price target raised to $1,350 from $1,300 at Evercore ISIMettler-Toledo price target raised to $1,350 from $1,300 at Evercore ISI
Wolfe Research Analyst forecast on GB:0K10
Michael Polark
Wolfe Research
Wolfe Research
$1,180
Hold
-11.31%
Downside
Initiated
06/01/26
Mettler-Toledo initiated with a Peer Perform at Wolfe ResearchMettler-Toledo initiated with a Peer Perform at Wolfe Research
Robert W. Baird Analyst forecast on GB:0K10
Catherine Ramsey Schulte
Robert W. Baird
Robert W. Baird
$1,445→$1,194
Hold
-10.25%
Downside
Reiterated
05/11/26
Mettler-Toledo price target lowered to $1,194 from $1,445 at BairdMettler-Toledo price target lowered to $1,194 from $1,445 at Baird
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PTGXProtagonist Therapeutics
AXGNAxoGen
ATECAlphatec Holdings
CABACabaletta Bio
ONCBeOne Medicines
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Mettler-Toledo

3 Months
Vijay KumarEvercore ISI
Success Rate
6/9 ratings generated profit
67%
Average Return
+1.94%
Copying Vijay Kumar's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +1.94% per trade.
1 Year
Vijay KumarEvercore ISI
Success Rate
8/9 ratings generated profit
89%
Average Return
+1.73%
Copying Vijay Kumar's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +1.73% per trade.
2 Years
Vijay KumarEvercore ISI
Success Rate
8/9 ratings generated profit
89%
Average Return
+2.92%
Copying Vijay Kumar's trades and holding each position for 2 Years would result in 88.89% of your transactions generating a profit, with an average return of +2.92% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0K10 Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
0
0
0
0
0
Buy
7
6
8
6
6
Hold
4
5
7
6
6
Sell
0
0
0
0
1
Strong Sell
0
0
0
0
0
total
11
11
15
12
13
In the current month, 0K10 has received 6 Buy Ratings, 6 Hold Ratings, and 1 Sell Ratings. 0K10 average Analyst price target in the past 3 months is 1,455.45.
Each month's total comprises the sum of three months' worth of ratings.

0K10 Financial Forecast

0K10 Earnings Forecast

Next quarter’s earnings estimate for 0K10 is $12.11 with a range of $12.07 to $12.25. The previous quarter’s EPS was $11.46. 0K10 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0K10 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 0K10 is $12.11 with a range of $12.07 to $12.25. The previous quarter’s EPS was $11.46. 0K10 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0K10 has Performed in-line its overall industry.

0K10 Sales Forecast

Next quarter’s sales forecast for 0K10 is $1.07B with a range of $1.07B to $1.07B. The previous quarter’s sales results were $1.03B. 0K10 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0K10 has Performed in-line its overall industry.
Next quarter’s sales forecast for 0K10 is $1.07B with a range of $1.07B to $1.07B. The previous quarter’s sales results were $1.03B. 0K10 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0K10 has Performed in-line its overall industry.

0K10 Stock Forecast FAQ

What is GB:0K10’s average 12-month price target, according to analysts?
Based on analyst ratings, Mettler-Toledo International’s 12-month average price target is 1,455.45.
    What is GB:0K10’s upside potential, based on the analysts’ average price target?
    Mettler-Toledo International has 9.40% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Mettler-Toledo International a Buy, Sell or Hold?
          Mettler-Toledo International has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 5 hold ratings and 1 sell ratings.
            What is Mettler-Toledo International’s share price target?
            The average share price target for Mettler-Toledo International is 1,455.45. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is $1,600.00 ,and the lowest forecast is $1,200.00. The average share price target represents 9.40% Increase from the current price of $1,330.43.
              What do analysts say about Mettler-Toledo International?
              Mettler-Toledo International’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of Mettler-Toledo International?
                To buy shares of GB:0K10, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.